Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2015 - 2019
Period Ending	Aug '25 Aug 8, 2025	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	Jul '20 Jul 31, 2020	Jul '19 Jul 31, 2019	2015 - 2019
Market Capitalization	1	8	14	7	3	3	Upgrade
Market Cap Growth	-66.44%	-40.41%	103.66%	174.57%	-25.87%	-17.43%	Upgrade
Enterprise Value	1	9	13	7	2	3	Upgrade
Last Close Price	0.01	0.09	0.16	0.35	0.35	0.35	Upgrade
PB Ratio	0.16	1.21	2.06	2.08	1.24	2.20	Upgrade
P/TBV Ratio	0.16	1.21	2.06	2.08	1.24	2.20	Upgrade
P/OCF Ratio	1.80	-	-	-	-	16.11	Upgrade
EV/FCF Ratio	-1.72	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.01	0.01	0.00	0.01	0.01	-	Upgrade
Quick Ratio	-0.35	0.80	2.10	3.13	2.50	1.07	Upgrade
Current Ratio	0.22	1.17	2.34	3.39	5.23	2.09	Upgrade
Return on Equity (ROE)	-8.58%	-8.97%	-26.30%	-20.91%	-12.23%	-17.89%	Upgrade
Return on Assets (ROA)	-6.99%	-6.75%	-13.63%	-11.65%	-8.75%	-13.05%	Upgrade
Return on Capital (ROIC)	-7.45%	-7.48%	-15.22%	-12.35%	-9.11%	-14.12%	Upgrade
Earnings Yield	-50.58%	-7.25%	-9.39%	-8.32%	-8.62%	-8.81%	Upgrade
FCF Yield	-68.56%	-29.83%	-27.57%	-13.68%	-27.54%	-4.95%	Upgrade
Buyback Yield / Dilution	14.80%	-14.41%	-76.61%	-24.40%	-20.52%	-27.13%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.